<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2221-2434</journal-id>
<journal-title><![CDATA[Revista Finlay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Finlay]]></abbrev-journal-title>
<issn>2221-2434</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Cienfuegos. Centro Provincial de información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2221-24342021000200182</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización sociodemográfica y patológica de pacientes con diabetes mellitus tipo 2 atendidos en un centro médico de Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Sociodemographic and Pathological Characterization of Patients with Type 2 Diabetes Mellitus Treated in Peru Medical Center]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Asenjo Alarcón]]></surname>
<given-names><![CDATA[José Ander]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Facultad de Ciencias de la Salud. Universidad Nacional Autónoma de Chota  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Perú</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>11</volume>
<numero>2</numero>
<fpage>182</fpage>
<lpage>188</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2221-24342021000200182&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2221-24342021000200182&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2221-24342021000200182&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Fundamento: la diabetes mellitus tipo 2 es una enfermedad crónica muy frecuente. Sus características y comorbilidades asociadas son bien conocidas, no obstante, la repuesta de los pacientes a los tratamientos convencionales no siempre es efectiva. Se requiere ampliar el conocimiento de las características particulares de cada paciente para lograr un manejo individualizado.  Objetivo:  describir las características sociodemográficas y patológicas de pacientes con diabetes mellitus tipo 2 atendidos en un centro médico de Chota, Perú.  Métodos:  se realizó un estudio descriptivo, transversal y retrospectivo, en 102 pacientes atendidos en el centro médico de salud de Chota en Perú efectuado durante febrero y marzo del 2015. Las características sociodemográficas y patológicas fueron las variables analizadas y se identificaron en una ficha de recolección de datos. Se describieron frecuencias absolutas, relativas, medidas de tendencia central, de dispersión e intervalos de confianza para proporciones al 95 %.  Resultados: el 81,4 % de los pacientes estaban casados, se desempeñaban como profesores en actividad o cesantes (52,0 %), con una edad promedio de 59 años (58,9 % de varones &#8805; 60 años y 56,5 % de mujeres entre 30 y 59 años), en tratamiento con glibenclamida + metformina (55,8 %) y dieta + ejercicio (75,5 %), con un tiempo de enfermedad promedio de 6,6 años (56,6 % de mujeres y 41,1 % de varones &#8804; 5 años).  Conclusión:  los pacientes con DM2 en su mayoría eran casados, profesores, con edad promedio de 59 años, en tratamiento con glibenclamida + metformina y dieta + ejercicio, presentaban la enfermedad por 6,6 años como promedio.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Background: type 2 diabetes mellitus is a very frequent chronic disease. Its characteristics and associated comorbidities are well known, however, the response of patients to conventional treatments is not always effective. It is necessary to increase the patients&#8217; particular characteristics knowledge to achieve individualized management.  Objective: to describe the sociodemographic and pathological characteristics of patients with type 2 diabetes mellitus treated in Chota medical center, Peru.  Methods: a descriptive, cross-sectional and retrospective study was carried out in 102 patients treated at the Chota medical health center in Peru, carried out during February and March 2015. Sociodemographic and pathological characteristics were the variables analyzed and were identified in a medical record data collection. Absolute and relative frequencies, measures of central tendency, dispersion and confidence intervals for proportions at 95 % were described.  Results: 81.4 % of the patients were married, worked as teachers in activity or unemployed (52.0 %), with an average age of 59 years old (58.9 % of men &#8805;60 years and 56.5 % of women between 30 and 59 years old), in treatment with glibenclamide + metformin (55.8 %) and diet + exercise (75.5 %), with an illness average time of 6.6 years (56.6 % of women and 41.1 % of males &#8804; 5 years).  Conclusion: the majority of patients with DM2 were married, teachers, with an average age of 59 years old, on treatment with glibenclamide + metformin and diet + exercise, they suffer from the disease for an average of 6.6 years.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diabetes mellitus tipo 2]]></kwd>
<kwd lng="es"><![CDATA[perfil de salud]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus type 2]]></kwd>
<kwd lng="en"><![CDATA[health profile]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Magliano]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sacre]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Harding]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Gregg]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Zimmet]]></surname>
<given-names><![CDATA[PZ]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Young-onset type 2 diabetes mellitus - implications for morbidity and mortality]]></article-title>
<source><![CDATA[Nat Rev Endocrinol]]></source>
<year>2020</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>321-31</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Twig]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Zucker]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Afek]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cukierman]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bendor]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Derazne]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adolescent Obesity and Early-Onset Type 2 Diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2020</year>
<volume>43</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1487-95</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Illness perceptions among patients with type 2 diabetes mellitus A cross-sectional study]]></article-title>
<source><![CDATA[Int J Nurs Pract]]></source>
<year>2020</year>
<volume>26</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Apostolova]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Iannantuoni]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gruevska]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muntane]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Victor]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of action of metformin in type 2 diabetes Effects on mitochondria and leukocyte-endothelium interactions]]></article-title>
<source><![CDATA[Redox Biol]]></source>
<year>2020</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>101517</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sargeant]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Zaccardi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Khunti]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes]]></article-title>
<source><![CDATA[Pharmaceuticals (Basel)]]></source>
<year>2020</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>427</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[FIdan]]></surname>
<given-names><![CDATA[Ö]]></given-names>
</name>
<name>
<surname><![CDATA[Takmak]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zeyrek]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Kartal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients With Type 2 Diabetes Mellitus Obstacles in Coping]]></article-title>
<source><![CDATA[J Nurs Res]]></source>
<year>2020</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<source><![CDATA[Instituto Nacional de Estadística e Informática. Guía para la evaluación de indicadores sociales de las encuestas de hogares]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Estadística e Informática]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>MINSA</collab>
<source><![CDATA[Resolución Ministerial N° 538-2009/MINSA. Modifican documento aprobado por R.M. Nº 729-2003-SA/DM en la clasificación de los Grupos Objetivo para los Programas de Atención Integral/2009 de 14 de agosto]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[Diario Oficial El Peruano]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Seguro Social de Salud del Perú (EsSalud)</collab>
<source><![CDATA[Guía de práctica clínica de diabetes mellitus tipo 2 para el primer nivel de atención]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[Seguro Social de Salud del Perú (EsSalud)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prates]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Prates]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Moura]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Carmo]]></surname>
<given-names><![CDATA[TM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas de clientes com hipertensão arterial e diabetes mellitus]]></article-title>
<source><![CDATA[Rev Enferm UFPE]]></source>
<year>2020</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspectos clínicos y epidemiológicos de pacientes ingresados por diabetes mellitus de tipo 2 en el hospital de Moa]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2020</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Valles]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto del contexto, rutinas y funcionamiento en la salud de familias mexicanas con diabetes tipo 2.]]></article-title>
<source><![CDATA[Cienc Enferm]]></source>
<year>2020</year>
<volume>26</volume>
<numero>18</numero>
<issue>18</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueredo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gafas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brossard]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Valdiviezo]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dimensiones de calidad de vida afectadas en pacientes diabéticos.]]></article-title>
<source><![CDATA[Rev Cubana Enferm]]></source>
<year>2020</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McCarthy]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vorderstrasse]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Portillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dickson]]></surname>
<given-names><![CDATA[VV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Managing Diabetes in the Workplace]]></article-title>
<source><![CDATA[Workplace Health Saf]]></source>
<year>2021</year>
<volume>69</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>216-23</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Abreu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cos]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿Cuándo empieza la diabetes? Detección e intervención tempranas en diabetes mellitus tipo 2.]]></article-title>
<source><![CDATA[Rev Clín Española]]></source>
<year>2020</year>
<volume>220</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
